CDR-Life has formed a successful partnership with Boehringer Ingelheim, bringing together our antibody fragment expertise with Boehringer’s clinical development and marketing expertise.
We are open to partnering with companies, academic collaborators, and individuals who share our vision and can help bring CDR-Life’s innovations to patients.
Our team has a substantial track record in both forming and working in partnerships between pharma and biotech companies to bring new therapeutics to market for patients.
«Partnering with CDR-Life provides Boehringer Ingelheim with the opportunity to collaborate with a team that has a proven track record developing antibody fragment-based therapeutics…»
Clive R. Wood, Ph.D., Corporate Senior Vice President and Global Head of Discovery Research, Boehringer Ingelheim
Contact us for partnering opportunities.
Cowen 43rd Annual Health Care Conference, March 6 – 8 in Boston, United States
Bio-Europe Spring 2023, March 20 – 22 in Basel, Switzerland
ASCO Annual Meeting 2023, June 2 – 6 in Chicago, United States
Bio International Convention 2023, June 5 – 8 in Boston, United States